ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

This table shows the Balance Sheet for ImmuneOnco Biopharmaceuticals (Shanghai) Inc. going from 2021 until 2023. The balance sheet is a financial statement that presents the financial position of a company at a specific point in time, typically at the end of a fiscal period. It consists of three main components: assets (such as cash, inventory, property, and investments), liabilities (including debts, loans, and obligations), and shareholders' equity (the residual interest in the company's assets after deducting liabilities). The balance sheet provides insights into a company's liquidity, solvency, and overall financial health.